IDEXX Laboratories Inc (IDXX) earnings · P/E 39, rev $4.30B
These earnings events as JSON? API free 100/dayIDEXX Laboratories Inc (IDXX) is a diagnostics & research company listed on NASDAQ.
This IDXX earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported IDXX revenue for 2025-12-31 was $4.30B. Net income was $1.06B. Revenue was up 10.4% from 2024-12-31 to 2025-12-31. IDXX currently screens at market cap $43.08B and trailing P/E 39.4.
When the next IDXX 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 10.4% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full IDXX research stays on the stock page; the tape stays on the quote page.
IDXX earnings FAQ
What are IDXX's latest revenue and net income?
Latest cached IDEXX Laboratories Inc (IDXX) revenue for Dec 31, 2025 was $4.30B. Net income was $1.06B. Statements: https://lician.com/financials/idxx
What is IDXX's latest diluted EPS?
Latest cached IDEXX Laboratories Inc (IDXX) diluted EPS for Dec 31, 2025 was $13.08.
What period does the latest IDXX earnings print cover?
The latest cached IDEXX Laboratories Inc (IDXX) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did IDXX revenue change from the prior cached period?
Cached IDEXX Laboratories Inc (IDXX) revenue was up 10.4% from $3.90B (Dec 31, 2024) to $4.30B (Dec 31, 2025). Statements: https://lician.com/financials/idxx
What is IDXX's P/E ratio?
IDEXX Laboratories Inc (IDXX) trailing P/E is 39.4 on the latest cached fundamentals snapshot.
Where are IDXX earnings listed?
Cached earnings facts for IDEXX Laboratories Inc (IDXX) are listed at https://lician.com/earnings/idxx. Statements: https://lician.com/financials/idxx
Not investment advice.